Endocyte (West Lafayette, IN) developer of folate-targeted based therapeutics for the treatment of renal cell carcinoma, ovarian, endometrial and nscl cancer raised $15M in a Series C financing. Participants included Sanderling Ventures, Burrill & Company, Triathlon Medical Ventures, Blue Chip Venture Company, American Bailey Ventures and CID Capital.

Regado Biosciences (Durham, NC) a biopharmaceutical company with a platform oligonucleotide drug-antidote pairing system focused upon the anticoagulant market has closed a $23M Series C financing. The deal was led by Caxton Advantage Life Sciences, Domain Associates, Quaker BioVentures and Aurora Funds.

CoreValve (Irvine, CA) is a medical device company introducing a percutaneous revalving system to replace failing aortic heart valves without surgical access closed a $33M Series C financing. The deal was led by Maverick Capital other participants included Apax Partners, HealthCap and Sofinnova Partners.

Phenomix (San Diego, Calif.) a drug discovery and development company focused on the treatment of Type 2 diabetes and hepatitis C raised a $55M Series C financing. The deal was led by Nomura Phase4 and joined by JPMorgan, Delphi Ventures, Baker Brothers, Alta Partners, Sofinnova Ventures, Bay City Capital, CMEA Ventures, Novartis Venture Fund and [...]

Transoma Medical (St. Paul, MN) maker of implantable wireless monitoring systems for patients with chronic cardiovascular disease closed a $13M Series C financing. The deal was led by Canaan Partners, Affinity Capital Management and Polaris Venture Partners.

Advanced BioHealing (La Jolla, CA) a regenerative medicine, artificial skin tissue and wound healing company raised $25.5M in Series C funding.The deal was led by Safeguard Scientific and was accompanied by Channel Medical Partners, Red Abbey Venture Partners, Canaan Partners and Wheatley Partners.

Cara Therapeutics (Tarrytown, NY) is an emerging biotechnology company focused on developing novel therapeutics to treat human diseases associated with pain and inflammation has closed a $24M Series C financing. Investors included Scottish Widows Investment Partnership, Mitsubishi International Corporation, MVM Life Science Partners, Alta Partners and Ascent Biomedical Ventures.

Phenomix (San Diego, CA) a drug discovery and development company focused on novel drugs to inhibit therapeutic targets in the protease and kinase families.The most advanced programs are for treatment of Type 2 diabetes and for treatment of hepatitis C. The deal was led by Nomura Phase4 Ventures and was joined by JP Morgan Partners, [...]

Cytochroma (Canada) a drug company focused on Psoriasis and chronic kidney disease raised Cnd$21M in Series C financing. Investors include VenGrowth Advanced Life Sciences Fund, Novo A/S and GeneChem Technologies Venture Fund.

MAKO Surgical (Ft. Lauderdale, FL) developer of a guidance system that aids in surgery for early-stage osteoarthritis of the knee raised $30 million in Series C funding. Investors included Tudor Investment Corp., Ziegler Meditech Equity Partners, The Exxel Group, MDS Capital, Aperture Venture Partners, Ivy Healthcare Capital and Sycamore Ventures.